<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Merck Sharp &amp; Dohme Corp. v. Ajanta Pharma Limited et al :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2020cv00815/72451</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2020cv00815/72451/feed" rel="self" type="application/rss+xml" />
        <pubDate>Tue, 10 Nov 2026 12:25:43 -0800</pubDate>
        <lastBuildDate>Tue, 10 Nov 2026 12:25:43 -0800</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>Merck Sharp &amp; Dohme Corp. v. Ajanta Pharma Limited et al - Docket Entries - Showing 1 through 12</description>
                                    <item>
        <title>
                            <![CDATA[Document 12]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz - filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. (Attachments: #1 Certification)(Bilson, David) Modified on 8/7/2020 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8931528</guid>
                <pubDate>
            Fri, 07 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 11]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Carolyn A. Blessing and Christopher J. Cassella - filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. (Attachments: #1 Certification, #2 Certification, #3 Certification)(Bilson, David) Modified on 8/7/2020 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8931526</guid>
                <pubDate>
            Fri, 07 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorneys Michael J. Gaertner, Carolyn A. Blessing, Christopher J. Cassella, David B. Abramowitz for Ajanta Pharma Limited and Ajanta Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8931530</guid>
                <pubDate>
            Fri, 07 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #12 MOTION for Pro Hac Vice Appearance of Attorney David B. Abramowitz, filed by Ajanta Pharma USA Inc., Ajanta Pharma Limited. Signed by Judge Richard G. Andrews on 8/7/2020. (nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8931529</guid>
                <pubDate>
            Fri, 07 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Carolyn A. Blessing and Christopher J. Cassella, filed by Ajanta Pharma USA Inc., Ajanta Pharma Limited. Signed by Judge Richard G. Andrews on 8/7/2020. (nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8931527</guid>
                <pubDate>
            Fri, 07 Aug 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 10]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ajanta Pharma Limited. (Phillips, John) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8931525</guid>
                <pubDate>
            Thu, 30 Jul 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 9]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ajanta Pharma Limited for Ajanta Pharma USA Inc. filed by Ajanta Pharma USA Inc.. (Phillips, John) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8931524</guid>
                <pubDate>
            Thu, 30 Jul 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 8]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to #1 Complaint and Affirmative Defenses, by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Phillips, John) Modified on 7/31/2020 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8931523</guid>
                <pubDate>
            Thu, 30 Jul 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Ajanta Pharma USA Inc. waiver sent on 6/19/2020, answer due 8/18/2020. (Silver, Daniel) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8931522</guid>
                <pubDate>
            Thu, 02 Jul 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Ajanta Pharma Limited waiver sent on 6/19/2020, answer due 8/18/2020. (Silver, Daniel) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8931521</guid>
                <pubDate>
            Thu, 02 Jul 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8931520</guid>
                <pubDate>
            Wed, 24 Jun 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (myr) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8138828</guid>
                <pubDate>
            Wed, 17 Jun 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (myr) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8138827</guid>
                <pubDate>
            Wed, 17 Jun 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than May 6, 2020. Date of Expiration of Patent: November 24, 2026.Thirty Month Stay Deadline: No earlier than 11/6/2022. (myr) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8138826</guid>
                <pubDate>
            Wed, 17 Jun 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8138825</guid>
                <pubDate>
            Wed, 17 Jun 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT filed against Ajanta Pharma Limited, Ajanta Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3000269.) - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(myr) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8138824</guid>
                <pubDate>
            Wed, 17 Jun 2020 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                No Summons Issued. (myr) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_8138829</guid>
                <pubDate>
            Wed, 17 Jun 2020 00:00:00 -0700
        </pubDate>
    </item>
                </channel>
</rss>
